Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion

肿瘤微环境衍生的胆固醇在 CD8 T 细胞耗竭中的作用

基本信息

  • 批准号:
    10456222
  • 负责人:
  • 金额:
    $ 41.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary Recently we discovered that cholesterol metabolically reprograms tumor-infiltrating T cells so that they become exhausted. Our unpublished, preliminary studies showed that tumor tissues have a much higher cholesterol content compared with normal tissues, and the PD-1high2B4high CD8+ T cells in tumor-infiltrating T cells have significantly higher cholesterol content than PD-1med2B4med cells, which in turn have significantly higher cholesterol content than PD-1low2B4low cells in different murine tumor models. The same was observed in human multiple myeloma and colon tumor samples of. We also showed that the PD-1high2B4high CD8+ T cells have significantly higher LAG-3 and TIM-3 (other T-cell exhaustion markers) expression than PD-1med2B4med cells, and the PD-1med2B4med cells have significantly higher LAG-3 and TIM-3 expression than PD-1low2B4low cells. Consistently, sorted PD-1high2B4high CD8+ T cells displayed much weaker cytolytic activity against target tumor cells than PD-1med2B4med CD8+ T cells. Adding cholesterol to the culture of tumor-specific CD8+ T cells upregulated their expression of PD-1 and other exhaustion markers and reduced their cytolytic activity. Conversely, reducing cholesterol content in sorted PD-1high2B4high tumor-infiltrating CD8+ T cells downregulated their expression of PD-1 and other exhaustion markers and enhanced their cytolytic activity. Based on these novel findings, we hypothe size that the tumor and its microenvironment induce effector T -cell exhaustion by using cholesterol to metabolically reprogram and upregulate the expression of immune inhibitory receptors and exhaustion markers on CD8+ cells. Aim 1 will determine the mechanisms underlying cholesterol-induced CD8+ T-cell exhaustion, and Aim 2 will reprogram CD8+ T-cell metabolism and/or the tumor microenvironment to enhance the antitumor effects of tumor-specific CD8+ T cells. Completing this project will give us in-depth understanding of the mechanisms involved in how tumor -derived cholesterol metabolically repr ograms tumor- infiltrating T cells so that they become exhausted. Understanding the mechanisms will allow us and others to identify novel therapeutic targets and develop new methods to improve the efficacy of T cell- or immune checkpoint blockade-based immunotherapy in cancer.
项目摘要 最近,我们发现胆固醇通过代谢重编程肿瘤浸润性T细胞, 变得筋疲力尽我们未发表的初步研究表明,肿瘤组织具有高得多的 胆固醇含量与正常组织相比,肿瘤浸润性T细胞中PD-1高2B 4高CD 8 + T细胞 细胞具有比PD-1 med 2B 4 med细胞显著更高的胆固醇含量,而PD-1 med 2B 4 med细胞又具有显著更高的胆固醇含量。 在不同的小鼠肿瘤模型中,胆固醇含量高于PD-1低2B 4低细胞。观察到同样的情况 在人类多发性骨髓瘤和结肠肿瘤样本中。我们还发现PD-1高2B 4高CD 8 + T细胞 LAG-3和TIM-3(其他T细胞耗竭标志物)的表达显著高于PD-1 med 2B 4 med PD-1 med 2B 4 med细胞的LAG-3和TIM-3表达显著高于PD-1 low 2B 4low细胞 细胞一致地,分选的PD-1高2B 4高CD 8 + T细胞显示出弱得多的针对靶细胞的细胞溶解活性。 PD-1 med 2B 4 med CD 8 + T细胞。向肿瘤特异性CD 8 + T细胞的培养物中添加胆固醇 上调它们的PD-1和其它耗竭标志物的表达并降低它们的细胞溶解活性。 相反,降低分选的PD-1高2B 4高肿瘤浸润性CD 8 + T细胞中的胆固醇含量下调 其表达PD-1和其它耗竭标志物并增强其细胞溶解活性。基于这些 新的发现,我们假设肿瘤及其微环境通过以下方式诱导效应T细胞耗竭 使用胆固醇来代谢重编程和上调免疫抑制受体的表达, CD 8+细胞的耗竭标志物。目的1将确定胆固醇诱导的CD 8 + T细胞的机制。 Aim 2将重新编程CD 8 + T细胞代谢和/或肿瘤微环境, 增强肿瘤特异性CD 8 + T细胞的抗肿瘤作用。完成这个项目将使我们深入了解 了解肿瘤来源的胆固醇代谢如何反映肿瘤的机制, 浸润T细胞使其衰竭。了解这些机制将使我们和其他人能够 确定新的治疗靶点并开发新的方法来提高T细胞或免疫系统的功效。 基于检查点阻断的癌症免疫疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qing Yi其他文献

Qing Yi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qing Yi', 18)}}的其他基金

Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
分泌IL-9的Tc9细胞诱导肿瘤焦亡的新机制
  • 批准号:
    10704861
  • 财政年份:
    2023
  • 资助金额:
    $ 41.7万
  • 项目类别:
Role of lipid metabolism in CD8+ T cell ferroptosis
脂质代谢在 CD8 T 细胞铁死亡中的作用
  • 批准号:
    10792062
  • 财政年份:
    2023
  • 资助金额:
    $ 41.7万
  • 项目类别:
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
肿瘤微环境衍生的胆固醇在 CD8 T 细胞耗竭中的作用
  • 批准号:
    10673683
  • 财政年份:
    2019
  • 资助金额:
    $ 41.7万
  • 项目类别:
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
肿瘤微环境衍生的胆固醇在 CD8 T 细胞耗竭中的作用
  • 批准号:
    10251255
  • 财政年份:
    2019
  • 资助金额:
    $ 41.7万
  • 项目类别:
Role of MIF in myeloma bone homing and drug response
MIF 在骨髓瘤骨归巢和药物反应中的作用
  • 批准号:
    9211149
  • 财政年份:
    2017
  • 资助金额:
    $ 41.7万
  • 项目类别:
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
靶向巨噬细胞使骨髓瘤对免疫检查点阻断敏感
  • 批准号:
    9634041
  • 财政年份:
    2017
  • 资助金额:
    $ 41.7万
  • 项目类别:
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
靶向巨噬细胞使骨髓瘤对免疫检查点阻断敏感
  • 批准号:
    10091406
  • 财政年份:
    2017
  • 资助金额:
    $ 41.7万
  • 项目类别:
Role of MIF in myeloma bone homing and drug response
MIF 在骨髓瘤骨归巢和药物反应中的作用
  • 批准号:
    10078263
  • 财政年份:
    2017
  • 资助金额:
    $ 41.7万
  • 项目类别:
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
靶向巨噬细胞使骨髓瘤对免疫检查点阻断敏感
  • 批准号:
    9283894
  • 财政年份:
    2017
  • 资助金额:
    $ 41.7万
  • 项目类别:
A novel T-cell subset able to kill relapsed cancers
一种能够杀死复发癌症的新型 T 细胞亚群
  • 批准号:
    9291443
  • 财政年份:
    2016
  • 资助金额:
    $ 41.7万
  • 项目类别:

相似海外基金

Significance of CD8-positive T lymphocytes in graft and recipient peripheral blood in the immunoresponse after allogeneic cord blood transplantation
移植者和受者外周血CD8阳性T淋巴细胞在同种异体脐带血移植后免疫反应中的意义
  • 批准号:
    20591149
  • 财政年份:
    2008
  • 资助金额:
    $ 41.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了